Predictive and Prognostic Survival Factors in Peritoneal Carcinomatosis from Appendiceal Cancer After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

Published on Dec 1, 2014in Annals of Surgical Oncology3.68
· DOI :10.1245/s10434-014-3869-1
William Jimenez6
Estimated H-index: 6
(Mercy Medical Center (Baltimore, Maryland)),
Armando Sardi19
Estimated H-index: 19
(Mercy Medical Center (Baltimore, Maryland))
+ 5 AuthorsVadim Gushchin14
Estimated H-index: 14
(Mercy Medical Center (Baltimore, Maryland))
Background Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has survival benefit in the treatment of selected patients with peritoneal carcinomatosis (PC) from appendiceal cancer (AC). We evaluated factors affecting the survival of patients with PC from AC after CRS/HIPEC.
  • References (44)
  • Citations (17)
#1Mehraneh D. Jafari (UCI: University of California, Irvine)H-Index: 11
#2Wissam J. Halabi (UCI: University of California, Irvine)H-Index: 17
Last.Alessio Pigazzi (UCI: University of California, Irvine)H-Index: 37
view all 7 authors...
#1A. Kuijpers (NKI-AVL: Netherlands Cancer Institute)H-Index: 6
#2Boj Mirck (NKI-AVL: Netherlands Cancer Institute)H-Index: 1
Last.A.J.A. Bremers (Radboud University Nijmegen)H-Index: 7
view all 13 authors...
#1Armando Sardi (Mercy Medical Center (Baltimore, Maryland))H-Index: 19
#2William Jimenez (Mercy Medical Center (Baltimore, Maryland))H-Index: 6
Last.Vadim Gushchin (Mercy Medical Center (Baltimore, Maryland))H-Index: 14
view all 6 authors...
#1L. H. Iversen (Aarhus University Hospital)H-Index: 5
#2P. C. Rasmussen (Aarhus University Hospital)H-Index: 5
Last.Søren Laurberg (Aarhus University Hospital)H-Index: 58
view all 4 authors...
#1Patrick Wagner (University of Pittsburgh)H-Index: 5
#2Frances Austin (University of Pittsburgh)H-Index: 7
Last.James F. Pingpank (University of Pittsburgh)H-Index: 28
view all 13 authors...
Cited By17
#1Carlos Munoz-Zuluaga (Mercy Medical Center (Baltimore, Maryland))H-Index: 1
#2Armando Sardi (Mercy Medical Center (Baltimore, Maryland))H-Index: 19
#1Carlos Munoz-Zuluaga (Mercy Medical Center (Baltimore, Maryland))H-Index: 1
#2Mary Caitlin King (Mercy Medical Center (Baltimore, Maryland))H-Index: 1
Last.Vadim Gushchin (Mercy Medical Center (Baltimore, Maryland))H-Index: 14
view all 8 authors...
#1W. J. van Eden (NKI-AVL: Netherlands Cancer Institute)H-Index: 3
#2N. Kok (NKI-AVL: Netherlands Cancer Institute)H-Index: 4
Last.Arend G. J. Aalbers (NKI-AVL: Netherlands Cancer Institute)H-Index: 10
view all 8 authors...
#1David J. Bartlett (Mayo Clinic)H-Index: 1
#2Paul G. Thacker (Mayo Clinic)H-Index: 2
Last.Christine O. Menias (Mayo Clinic)H-Index: 1
view all 11 authors...
View next paperDisseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".